Brand name – Hepcfix
Generic name – Daclatasvir
Manufacturer – Dr. Reddy’s Laboratories Ltd
Strength – 60 mg
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Salt composition – Daclatasvir 60 mg
Indication – Used in the treatment of chronic Hepatitis C Virus (HCV) infection
Gender – Unisex
Packaging – Bottle of 28 tablets
Prescription required – Yes
Description
Hepcfix 60 mg tablet is an antiviral medicine, used with other medicines in the
treatment of Chronic Hepatitis C Virus (HCV) infection in adults. It lowers the
multiplication of the virus (HCV) in the body. It improves liver function and helps to
eliminate the virus from the body over a period of time. The active ingredient of Hepcfix
60 mg tablet is Daclatasvir.
Pharmacodynamics
The combination of daclatasvir, sofosbuvir, and ribavirin is a direct-acting antiviral
(DAA) regimen for the treatment of hepatitis C virus (HCV) infection. That is why this
medication is given with other medications to treat Hepatitis C Virus. The inclusion of
newer effective DAAs such as SOF and DCV (high efficacy and excellent tolerance)
introduced a new method in HCV infection therapy: high rates of sustained virological
response (SVR), shorter therapies, less toxicity, and interferon-free treatments. This
combination was approved for the treatment of HCV in treatment-naive or treatment-
experienced patients with chronic HCV genotype 1 or 3 infections.
Contraindications
This tablet is contraindicated for patients who have a known allergy to any of the
ingredients of this medicine.
Alternate brands
● Daclacure 60 mg tablet
● Natdac 60 tablet
● Dalsiclear 600 tablet
● Hepcdac 60 mg tablet
● Mydekla 60 tablet


